Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB
Condition:   Aortic Valve Insufficiency Interventions:   Drug: Sacubitril-valsartan;   Drug: Amlodipine-losartan Sponsor:   Samsung Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials